av/vaxcyte--big.svg

COM:VAXCYTE

Vaxcyte

  • Stock

USD

Last Close

88.39

22/11 21:00

Market Cap

8.81B

Beta: -

Volume Today

1.61M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-29.48M
-
-50.27M
70.51%
-89.22M
77.46%
-100.08M
12.17%
-223.49M
123.31%
-402.27M
80.00%
depreciation and amortization
1.04M
-
1.23M
18.80%
1.41M
14.04%
3.46M
146.05%
9.20M
166.01%
10.17M
10.60%
deferred income tax
51K
-
1K
98.04%
301K
30,000%
-11.22M
-
stock based compensation
749K
-
1.19M
58.21%
5.43M
358.57%
10.73M
97.44%
23.65M
120.43%
48.76M
106.17%
change in working capital
1.90M
-
3.91M
106.23%
35.27M
802.51%
-37.01M
204.92%
12.74M
134.42%
81.32M
538.45%
accounts receivables
1.27M
-
868K
31.44%
inventory
-1.19M
-
2.87M
341.79%
accounts payables
1.27M
-
868K
31.44%
26.10M
2,907.14%
-12.47M
147.77%
2.90M
123.22%
11.22M
287.60%
other working capital
550K
-
-698K
226.91%
9.17M
1,413.47%
-24.54M
367.62%
9.84M
140.11%
70.09M
612.28%
other non cash items
-4.71M
-
-3.20M
32.17%
179K
105.60%
1.50M
739.66%
7.30M
386.03%
-23.55M
422.38%
net cash provided by operating activities
-30.47M
-
-47.15M
54.75%
-46.63M
1.10%
-121.39M
160.34%
-170.60M
40.53%
-296.79M
73.97%
investments in property plant and equipment
-1.77M
-
-1.20M
32.64%
-1.16M
3.35%
-6.55M
467.53%
-5.85M
10.79%
-67.88M
1,060.69%
acquisitions net
50K
-
26K
48%
7K
73.08%
51.81M
740,114.29%
purchases of investments
-336.34M
-
-102.75M
69.45%
-1.33B
1,194.37%
sales maturities of investments
130.56M
-
183.17M
40.29%
624.46M
240.92%
other investing activites
1K
-
-51.81M
-
net cash used for investing activites
-1.77M
-
-1.20M
32.60%
-1.10M
7.53%
-212.31M
19,113.39%
74.58M
135.13%
-773.31M
1,136.82%
debt repayment
-283K
-
-278K
1.77%
-61K
78.06%
common stock issued
42.94M
-
267.38M
522.64%
13.90M
94.80%
856.48M
6,063.50%
643.69M
24.84%
common stock repurchased
374K
-
888K
137.43%
1.03M
16.33%
2.04M
97.29%
dividends paid
-374K
-
other financing activites
62.47M
-
-1.10M
101.76%
107.56M
9,904.56%
3.01M
97.20%
4.03M
33.93%
-5.91M
246.60%
net cash used provided by financing activities
62.19M
-
41.57M
33.16%
374.87M
801.85%
17.80M
95.25%
861.55M
4,741.24%
639.81M
25.74%
effect of forex changes on cash
-341K
-
87K
125.51%
-439K
604.60%
137K
131.21%
-6.69M
4,980.29%
net change in cash
29.95M
-
-7.11M
123.75%
327.22M
4,699.72%
-316.34M
196.68%
765.67M
342.04%
-437.21M
157.10%
cash at beginning of period
36.14M
-
66.09M
82.88%
58.98M
10.76%
386.20M
554.84%
69.86M
81.91%
834.66M
1,094.83%
cash at end of period
66.09M
-
58.98M
10.76%
386.20M
554.84%
69.86M
81.91%
835.53M
1,096.07%
397.45M
52.43%
operating cash flow
-30.47M
-
-47.15M
54.75%
-46.63M
1.10%
-121.39M
160.34%
-170.60M
40.53%
-296.79M
73.97%
capital expenditure
-1.77M
-
-1.20M
32.64%
-1.16M
3.35%
-6.55M
467.53%
-5.85M
10.79%
-67.88M
1,060.69%
free cash flow
-32.24M
-
-48.34M
49.94%
-47.78M
1.15%
-127.95M
167.77%
-176.44M
37.90%
-364.67M
106.67%

All numbers in USD (except ratios and percentages)